Mary Wasserman and Son File Lawsuit Against Manufacturers of Risperdal
A mother and her son have filed a lawsuit against Johnson & Johnson and Jansseen Pharmaceuticals, the makers and manufacturers of Risperdal. Mary Wasserman, mother to 26-year-old Andrew Wasserman, claims that Risperdal, prescribed to her son after medications failed, caused embarrassing and troubling side effects. Since starting to take the medication, Andrew has developed breasts as part of a condition called gynecomastia. He has had to have a double mastectomy to have the breasts removed.
Rispedral has been approved by the FDA since 1993 to treat several medical conditions, including schizophrenia. It was only in 2007, however, when it was approved for children ages 13-17. It has also been approved to treat bipolar disorder in children ages 10-17 and for children and young adults with autism. However, a study released in 2006 by Duke researchers showed that children who took Risperdal had higher prolactin levels. Higher levels of this hormone promote breast development in women and men but in men, the increase leads to enlarged breasts, difficult producing sperm and decreased sexual ability.
Johnson & Johnson and Janssen Pharmaceuticals recently paid $2.2 billion in November of 2013 to resolve charges regarding the marketing of the drug. The gains made my families through litigation give hope to others that they too can be compensated for the psychological and physical trauma they have endured because of Rispedral.
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Risperdal’s dangerous side effects and the following psychological trauma. If you or a loved one have taken Risperdal and have experienced abnormal breast growth or milk production we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati at firstname.lastname@example.org, or by calling our office at 1.866.705.7584.
About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing testosterone replacement therapy victims and families harmed by dangerous treatments on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at email@example.com or by calling 1.866.705.7584.